Backed by over $600,000 in research funding, Accord and McLean Hospital are pioneering the first comprehensive study to identify the biological markers that could guide a new era in psychiatry.
FOR IMMEDIATE RELEASE
Arlington, Massachusetts – September 10, 2025
ACCORD is proud to announce that the Baszucki Group has awarded more than $600,000 in research funding to support a groundbreaking study on metabolic psychiatry in partnership with McLean Hospital. This three-year project, led by Dr. Virginie-Anne Chouinard and Dr. Matthew Bernstein, along with a dedicated research assistant and biostatistician, will explore how ketogenic and other metabolic interventions influence psychiatric symptoms, metabolic health and overall functioning..
Unlike studies that focus only on outcomes, this research aims to uncover specific biomarkers clinicians can track to guide treatment. By following clients during their time at Accord and in the months after discharge, the team will study how metabolic interventions affect both short and long-term recovery trajectories.
“This is about more than demonstrating symptom reduction; it’s about creating a roadmap for clinicians of how to best deliver metabolic psychiatry,” said Dr. Matthew Bernstein, CEO of Accord.
Accord’s role in this study underscores its position as a leader in advancing the science of mental health treatment. As the country’s first residential program devoted to metabolic psychiatry, Accord offers clients immersive and effective real-world care, while shaping the research that will guide the field.
Why It Matters:
- Will clarify the metabolic markers tied to psychiatric outcomes
- Provide evidence of the effectiveness of an immersive metabolic psychiatry intervention in a real world setting
- Tracks recovery beyond discharge, showing how metabolic and mental health improvements endure over time
This research is a vital step toward reimagining how we treat mental illness by addressing its metabolic roots and, for the first time, having measurable biomarkers for mental health recovery.
See how these same protocols are already making an impact at Accord
